Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ATM |
Variant | L2890I |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | ATM L2890I lies within the PI3K/PI4K catalytic domain of the Atm protein (UniProt.org). L2890I has been identified in sequencing studies (PMID: 32321774, PMID: 33272240), but has not been biochemically characterized and therefore, its effect on Atm protein function is unknown (PubMed, Jun 2024). |
Associated Drug Resistance | |
Category Variants Paths |
ATM mutant ATM L2890I |
Transcript | NM_000051.4 |
gDNA | chr11:g.108347362C>A |
cDNA | c.8668C>A |
Protein | p.L2890I |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011542843.2 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
NM_000051.4 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_047426976.1 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_047426975.1 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_017017789.2 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_047426978.1 | chr11:g.108354857_108354859delCTGinsATC | c.8668_8670delCTGinsATC | p.L2890I | RefSeq | GRCh38/hg38 |
NM_000051.3 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_006718843.5 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_005271562.6 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
NM_001351834.2 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_005271562.5 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_006718843.4 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_011542840.4 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_011542842.4 | chr11:g.108354857_108354859delCTGinsATC | c.8668_8670delCTGinsATC | p.L2890I | RefSeq | GRCh38/hg38 |
XM_047426977.1 | chr11:g.108354857_108354859delCTGinsATC | c.8668_8670delCTGinsATC | p.L2890I | RefSeq | GRCh38/hg38 |
XM_047426979.1 | chr11:g.108354857_108354859delCTGinsATC | c.8668_8670delCTGinsATC | p.L2890I | RefSeq | GRCh38/hg38 |
XM_011542840.3 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_011542843.3 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_017017790.3 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
NM_001351834.1 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
XM_017017790.2 | chr11:g.108347362C>A | c.8668C>A | p.L2890I | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|